Biocytogen’s APAC business development team is excited to exhibit and host 1-on-1 meetings at BIO Asia–Taiwan 2025, from July 24–27 in Taipei!
Join us at booth N1009 to explore:
Biocytogen has developed over 3,500 gene-edited mouse models, including more than 1,100 humanized target models. With deep expertise in multi-targeted humanized mice, we enable in vivo studies for bispecific/trispecific antibodies, as well as combination therapies.
📍 Booth N1009
📅 Time: July 24–27, 2025
📍 Location: Hall 1, 4F, Nangang Exhibition Center, Taipei
BIO Asia–Taiwan 2025 is one of the largest and most influential biotechnology events in Asia. This year’s exhibition, themed “The Next Wave of Biotech Opportunities,” will highlight the region’s breakthrough potential and showcase how technological innovation is tackling global challenges. Asia is emerging as both a wave maker and a game changer, driving the next leap in biotech development.
The event will feature over 850 exhibitors across 2,200 booths, covering 14 major sectors such as pharmaceuticals and medical devices, CDMO and CRO services, biotech solutions, biosimilars, multinational corporations, national and international pavilions, cell and regenerative medicine, precision medicine, pharmaceutical equipment, research institutions, incubators, and smart healthcare.
Want to explore partnership opportunities with us? Schedule a 1-on-1 meeting today by scanning the QR code in the image or clicking here!
